Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease

Opis bibliograficzny
Główni autorzy:	Petousi, N, Pavord, ID, Kent, BD
Format:	Journal article
Język:	English
Wydane:	BMJ Publishing Group 2024

Podobne zapisy

Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report
od: McDonald, VM, i wsp.
Wydane: (2019)

A new approach to the classification and management of airways diseases: identification of treatable traits
od: Shrimanker, R, i wsp.
Wydane: (2017)

Change is in the air: key questions on the ‘Treatable Traits’ model for chronic airway diseases in primary care
od: Alvar Agusti, i wsp.
Wydane: (2024-07-01)

Influence of sex, cigarette smoking and airway inflammation on treatable traits in CBIOPRED severe asthma
od: Cong Dong, i wsp.
Wydane: (2022-09-01)

From treatable traits to GETomics in airway disease: moving towards clinical practice
od: Alberto Papi, i wsp.
Wydane: (2024-01-01)

Patient activation is a treatable trait in patients with chronic airway diseases: An observational study
od: Jeannette B. Peters, i wsp.
Wydane: (2022-10-01)

Treatable traits in an English cohort: prevalence and predictors of future decline in lung function and quality of life in COPD
od: Muhammad Rehan Sarwar, i wsp.
Wydane: (2021-05-01)

Occluding mucous airway plugs in patients with obstructive lung diseases: a new treatable trait?
od: Alvar Agustí, i wsp.
Wydane: (2025-01-01)

Measuring lung function in airways diseases: current and emerging techniques
od: Petousi, N, i wsp.
Wydane: (2019)

Application of modern molecular microbiological techniques to identify treatable chronic bacterial airway infection in severe asthma
od: Jabeen, M, i wsp.
Wydane: (2018)

Walking the path of treatable traits in interstitial lung diseases
od: Francesco Amati, i wsp.
Wydane: (2023-10-01)

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?
od: Hinks, TSC, i wsp.
Wydane: (2022)

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?
od: Mary Ashley Brown, i wsp.
Wydane: (2022-09-01)

Lung Hyperinflation as Treatable Trait in Chronic Obstructive Pulmonary Disease: A Narrative Review
od: Koopman M, i wsp.
Wydane: (2024-07-01)

Identification of pulmonary treatable traits in a real-life setting
od: Simpson, J, i wsp.
Wydane: (2018)

A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future
od: Pérez de Llano L, i wsp.
Wydane: (2020-09-01)

Treatable Traits in Chronic Respiratory Disease: A Comprehensive Review
od: Yong Qin Lee, i wsp.
Wydane: (2021-11-01)

Asthma control, airway responsiveness and airway inflammation.
od: Pavord, I
Wydane: (2009)

Associations between blood eosinophils and decline in lung function among adults with and without asthma
od: Hancox, RJ, i wsp.
Wydane: (2018)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
od: Bafadhel M, i wsp.
Wydane: (2015-06-01)

Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.
od: Newby, C, i wsp.
Wydane: (2014)

Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma
od: Newby, C, i wsp.
Wydane: (2014)

Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough.
od: Birring, S, i wsp.
Wydane: (2004)

Biomarkers in severe asthma: Identifying the treatable trait
od: Aanchal Gvalani, i wsp.
Wydane: (2023-01-01)

The Lancet COPD Commission: broader questions remain
od: Petousi, N, i wsp.
Wydane: (2023)

Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma
od: José Antonio Castillo, MD, PhD, i wsp.
Wydane: (2023-11-01)

Non-invasive assessment of airway inflammation
od: Pavord, I, i wsp.
Wydane: (2009)

Sub-stratification of type-2 high airway disease for therapeutic decision-making: a ‘bomb' (blood eosinophils) meets ‘magnet' (FeNO) framework
od: Couillard, S, i wsp.
Wydane: (2022)

The treatable traits of asthma in pregnancy: a clinical audit
od: Katarzyna Duszyk, i wsp.
Wydane: (2024-06-01)

Treatable Traits in COPD – A Proposed Approach
od: Cardoso J, i wsp.
Wydane: (2021-11-01)

Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease
od: Wang H, i wsp.
Wydane: (2016-09-01)

Sputum induction to assess airway inflammation: is it an inflammatory stimulus?
od: Pavord, I
Wydane: (1998)

Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment
od: Peter A. Jacobsen, i wsp.
Wydane: (2021-05-01)

Airway function and markers of airway inflammation in patients with treated hypothyroidism.
od: Birring, S, i wsp.
Wydane: (2005)

Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis
od: Andrea Gramegna, i wsp.
Wydane: (2023-12-01)

Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD?
od: Cazzola M, i wsp.
Wydane: (2023-09-01)

Bringing the treatable traits approach to primary care asthma management
od: Paul E. Pfeffer, i wsp.
Wydane: (2023-09-01)

Treatment of severe stable COPD: the multidimensional approach of treatable traits
od: Marlies van Dijk, i wsp.
Wydane: (2020-09-01)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
od: Siva R, i wsp.
Wydane: (2014-02-01)

Non-invasive assessment of airway inflammation in asthma: An overview
od: Shaw, D, i wsp.
Wydane: (2006)